drugset / Trial / NCT00945945
A Study of Duloxetine in Patients With Osteoarthritis Knee Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to determine if duloxetine 60 mg once daily (QD) reduces pain severity in patients with osteoarthritis (OA) knee pain compared with placebo.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-05
- Completion
- 2010-05
Outcome
Missed primary endpoint
registry analysis (superiority or other test); DLX30-PLA vs PLA-DLX60; p = 0.105; Least Squares Mean Difference 0.34 (95% CI -0.07 to 0.75); ANCOVA NCT00945945 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | Oral |